WebSep 21, 2024 · WALTHAM, Mass., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing … WebSep 17, 2024 · A muscle disease company, Dyne Therapeutics ( DYN) has priced its IPO of 12,251,578 common shares at $19.00/share, for expected gross proceeds of ~$233M. Trading kicks off September 17. The ...
IPO Launch: Dyn Therapeutics Proposes $175 Million IPO
WebSep 17, 2024 · After pricing its shares at $19 each — up from the range of $16 to $18 it had stipulated — the shares increased in value by 28% as of 2:30 p.m. on Thursday. The company is developing ... WebDyne Therapeutics, Inc. Financial Information: Market Cap: $707.8mil: Revenues: $0 mil (last 12 months) Net Income $-28.2 mil (last 12 months) IPO Profile: Symbol: DYN: Exchange: NASDAQ: Shares (millions): 12.3: Price range: $19.00 - $19.00: Est. $ Volume ... Priced: Quiet Period Expiration Date: Available only to Subscribers: Lock-Up Period ... the barber room rickmansworth
IPO Update: Dyne Therapeutics Readies $175 Million IPO
WebDyne Therapeutics Inc. Follow. Share. $8.82. After Hours: $8.82 (0.00%) 0.00. ... Total number of common shares outstanding as of the latest date disclosed in a financial filing. WebSep 16, 2024 · WALTHAM, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases, … WebSep 17, 2024 · CureDuchenne celebrates Dyne Therapeutics’ public offering on the Nasdaq, under the ticker “DYN”. Today’s initial public offering (IPO) will elevate Dyne’s financial position and accelerate Dyne’s lead programs, which includes Duchenne muscular dystrophy. CureDuchenne values companies like Dyne that utilize fundraising tools such … the barberry bsmhft